Prenatal Chromosomal Array CGH Test
Chromosomal Array CGH - Prenatal, Amniotic Fluid Price
Chromosomal Array, Comparative genomic hybridization (CGH) is a confirmatory & an invasive test which is done prenatally to identify foetal anomalies i.e., chromosomal aneuploidy, other large structural changes, sub microscopic abnormalities that are not detected by karyotyping. CGH Chromosome Array Test requires detailed clinical history including anomaly scan report and a duly filled consent form (Form G)
Array CGH Prenatal helps in the detection of copy number variations (CNV) changes (microdeletions and microduplications).
Conventional karyotyping is used to detect chromosomal problems in about 35% of pregnancies. However, its accuracy depends on the quantity and type of fetal ultrasonography anomalies present. Prenatal karyotyping is a reliable procedure that can identify the majority of germline chromosomal abnormalities. Most of these anomalies are associated with the phenotype. For postnatal diagnosis of people with congenital defects and intellectual incapacity, array-comparative genomic hybridization (CGH)/(single nucleotide polymorphism is very common. It has a high probability of accurate abnormality detection and is automation-friendly. This makes it the perfect choice for a prenatal diagnosis.
To discover fetal defects such as chromosomal aneuploidy, other significant structural changes, and submicroscopic abnormalities that are not picked up by karyotyping, a confirming and invasive test called CGH is performed during pregnancy. A complete consent form and a clinical history that includes the anomaly scan report are required for the test (Form G).
CGH has been established to aid in prenatal diagnosis. It is used to examine structural chromosomal rearrangements linked to copy number variations on a genome-wide scale. Test and standard genomic DNAs are fluorescently labeled with two separate fluorochromes and hybridized to healthy metaphase chromosomes in CGH. Genome-wide copy number alterations, such as homo- or heterozygous deletions, gains, or amplifications, can be detected by determining the relative genomic copy number throughout each chromosome.
Written by: Dr Vishal Wadhwa M.D, D.N.B Microbiology, Medical Affairs
Frequently asked questions
Find quick answers to the most common questions about health tests, bookings, and reports.
Regular exercise, a balanced diet, avoiding smoking, maintaining a healthy weight, and managing stress all help reduce heart disease risk.
Common signs include irritability, trouble sleeping, headaches, difficulty concentrating, and muscle tension.
Ratings & Reviews
We're satisfying our customers every day since 1980.
Choose precision On time, every time!
- 98% on time collections with a 60 minutes promise
- Real-time tracking of phlebotomist arrival and report generation
- Fully digital report delivery—view from mobile or desktop instantly
- Continuous monitoring of turnaround times to ensure accuracy and speed
- Dedicated support team to resolve any delays or queries quickly
Why Metropolis Healthcare?
Metropolis has been present for over 40 years in the market.
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
0
Years of experience
170+
Advanced Labs
Trusted by
Leading Doctors & Hospitals
2,000+
Scientific Officers
Proficiency Testing
for Accurate Reports
Latest Blogs & News
Stay informed with our expert insights and updates.
About Us
Metropolis Healthcare is a leading diagnostic service provider in India. We are a team of dedicated professionals committed to ensuring you and your family receive the most accurate and timely healthcare solutions. We believe in making health care accessible, affordable and evidence-based. Our expert panel are equipped with the latest technology and manned by a certified team of over 4000+ technicians.
In diagnostic services, we have more than three decades of experience servicing diverse stakeholders health advantage packages for men, women and seniors, genetic fitness & corporation in over 650+ tests like Oncology, Neurology, Gynaecology, Haematology, and many more. Our diagnostic services are located in leading doctors and clinics and serve over 15+ cities in India.